160 related articles for article (PubMed ID: 30355586)
1. Benign notochordal cell tumour: clinicopathology and molecular profiling of 13 cases.
Du J; Xu L; Cui Y; Liu Z; Su Y; Li G
J Clin Pathol; 2019 Jan; 72(1):66-74. PubMed ID: 30355586
[TBL] [Abstract][Full Text] [Related]
2. Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them.
Kreshak J; Larousserie F; Picci P; Boriani S; Mirra J; Merlino B; Brunocilla E; Vanel D
Cancer Imaging; 2014 Apr; 14(1):4. PubMed ID: 25609192
[TBL] [Abstract][Full Text] [Related]
3. Chordoma concurrent with benign notochordal cell tumor of the mobile spine. Should the chordoma part be biopsied? - A stepwise approach for management.
Samargandi R; de Pinieux G; Amelot A; Le Nail LR
Neurochirurgie; 2023 Nov; 69(6):101488. PubMed ID: 37696448
[TBL] [Abstract][Full Text] [Related]
4. Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma.
Deshpande V; Nielsen GP; Rosenthal DI; Rosenberg AE
Am J Surg Pathol; 2007 Oct; 31(10):1573-7. PubMed ID: 17895760
[TBL] [Abstract][Full Text] [Related]
5. Atypical Notochordal Cell Tumors: A Series of Notochordal-derived Tumors That Defy Current Classification Schemes.
Carter JM; Wenger DE; Rose PS; Inwards CY
Am J Surg Pathol; 2017 Jan; 41(1):39-48. PubMed ID: 27819871
[TBL] [Abstract][Full Text] [Related]
6. Benign notochordal cell tumors of the spine: natural history of 8 patients with histologically confirmed lesions.
Iorgulescu JB; Laufer I; Hameed M; Boland P; Yamada Y; Lis E; Bilsky M
Neurosurgery; 2013 Sep; 73(3):411-6. PubMed ID: 23719057
[TBL] [Abstract][Full Text] [Related]
7. Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of brachyury and galectin-3.
Shen J; Li CD; Yang HL; Lu J; Zou TM; Wang DL; Deng M
J Clin Neurosci; 2011 Jan; 18(1):96-9. PubMed ID: 20855213
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin.
Kikuchi Y; Yamaguchi T; Kishi H; Azuhata K; Kimizuka G; Hiroshima K; Nakatani Y
Am J Surg Pathol; 2011 Aug; 35(8):1158-64. PubMed ID: 21716081
[TBL] [Abstract][Full Text] [Related]
9. Chordoma arising from benign multifocal notochordal tumors.
Arain A; Hornicek FJ; Schwab JH; Chebib I; Damron TA
Skeletal Radiol; 2017 Dec; 46(12):1745-1752. PubMed ID: 28776089
[TBL] [Abstract][Full Text] [Related]
10. Intraosseous benign notochordal cell tumor.
Amer HZ; Hameed M
Arch Pathol Lab Med; 2010 Feb; 134(2):283-8. PubMed ID: 20121620
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) status in chordoma.
Ptaszyński K; Szumera-Ciećkiewicz A; Owczarek J; Mrozkowiak A; Pekul M; Barańska J; Rutkowski P
Pol J Pathol; 2009; 60(2):81-7. PubMed ID: 19886182
[TBL] [Abstract][Full Text] [Related]
12. The surgical pathology of notochordal remnants in adult intervertebral disks: a report of 3 cases.
Wang WL; Abramson JH; Ganguly A; Rosenberg AE
Am J Surg Pathol; 2008 Aug; 32(8):1123-9. PubMed ID: 18545146
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features of notochordal tumors: a study of 48 cases].
Huang J; Yang TT; Jiang ZM; Zhang HZ
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):201-206. PubMed ID: 33677882
[No Abstract] [Full Text] [Related]
14. [Chordoma: diagnostic considerations and review of the literature].
Conforti R; Sardaro A; Tecame M; Rossi C; Vargas O; Raucci A; Sica A
Recenti Prog Med; 2013; 104(7-8):322-7. PubMed ID: 24042401
[TBL] [Abstract][Full Text] [Related]
15. Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.
Yamaguchi T; Imada H; Iida S; Szuhai K
Surg Pathol Clin; 2017 Sep; 10(3):637-656. PubMed ID: 28797506
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
[TBL] [Abstract][Full Text] [Related]
17. Differentiating benign notochordal cell tumors from chordomas: radiographic features on MRI, CT, and tomography.
Nishiguchi T; Mochizuki K; Ohsawa M; Inoue T; Kageyama K; Suzuki A; Takami T; Miki Y
AJR Am J Roentgenol; 2011 Mar; 196(3):644-50. PubMed ID: 21343509
[TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
[TBL] [Abstract][Full Text] [Related]
19. First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions.
Yamaguchi T; Yamato M; Saotome K
Skeletal Radiol; 2002 Jul; 31(7):413-8. PubMed ID: 12107574
[TBL] [Abstract][Full Text] [Related]
20. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
